Mighty Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 67

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 11

Mighty Therapeutics General Information

Description

Developer of novel therapeutic compounds designed for the treatment of mitochondrial dysfunctions. The company offers injectable cardiolipin binders and small molecules for Barth syndrome and dry age-related macular degeneration, enabling patients to improve muscle strength and slow disease progression through therapies that address underlying mitochondrial dysfunction.

Contact Information

Formerly Known As
Stealth Peptides, Stealth BioTherapeutics
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 123 Highland Avenue
  • Suite 201
  • Needham, MA 02494
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Former Stock Listing
MITO
Corporate Office
  • 123 Highland Avenue
  • Suite 201
  • Needham, MA 02494
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mighty Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mighty Therapeutics‘s full profile, request access.

Request a free trial

Mighty Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutic compounds designed for the treatment of mitochondrial dysfunctions. The company offers in
Drug Discovery
Needham, MA
67 As of 2026

Cambridge, MA

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mighty Therapeutics Competitors (49)

One of Mighty Therapeutics’s 49 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
Cognition Therapeutics Formerly VC-backed New York, NY
Enterome Venture Capital-Backed Paris, France
Abliva Formerly VC-backed Lund, Sweden
Rein Therapeutics Formerly VC-backed Austin, TX
You’re viewing 5 of 49 competitors. Get the full list »

Mighty Therapeutics Patents

Mighty Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260345720-A1 Compositions, drug products, methods, and related uses for addressing dry age-related macular degeneration Pending 25-Apr-2025
WO-2026227068-A1 Compositions, drug products, methods, and related uses for addressing dry age-related macular degeneration Pending 25-Apr-2025
WO-2026155975-A1 Mitochondria-targeting cyclic peptides Pending 14-Jan-2025
WO-2026151846-A1 Compositions for use in the treatment of heart failure, idiopathic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, hypertrophic cardiomyopathy, or hypertensive cardiomyopathy Pending 09-Jan-2025
WO-2026151834-A1 Compounds for use in medical management of subjects with muscular dystrophy Pending 09-Jan-2025 A61K38/07
To view Mighty Therapeutics’s complete patent history, request access »

Mighty Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mighty Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Mighty Therapeutics‘s full profile, request access.

Request a free trial

Mighty Therapeutics FAQs

  • When was Mighty Therapeutics founded?

    Mighty Therapeutics was founded in 2005.

  • Where is Mighty Therapeutics headquartered?

    Mighty Therapeutics is headquartered in Needham, MA.

  • What is the size of Mighty Therapeutics?

    Mighty Therapeutics has 67 total employees.

  • What industry is Mighty Therapeutics in?

    Mighty Therapeutics’s primary industry is Drug Discovery.

  • Is Mighty Therapeutics a private or public company?

    Mighty Therapeutics is a Private company.

  • What is Mighty Therapeutics’s current revenue?

    The current revenue for Mighty Therapeutics is .

  • How much funding has Mighty Therapeutics raised over time?

    Mighty Therapeutics has raised $150M.

  • Who are Mighty Therapeutics’s investors?

    Morningside Group and Cornell University have invested in Mighty Therapeutics.

  • Who are Mighty Therapeutics’s competitors?

    AnTolRx, Cognition Therapeutics, Enterome, Abliva, and Rein Therapeutics are some of the 49 competitors of Mighty Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process